Contact your trial team or GP promptly if you experience: Persistent or severe nausea, vomiting, or diarrhoea that prevents adequate fluid or food intake Signs of dehydration, such as dizziness, dark urine, or reduced urination Severe or persistent abdominal pain, which may rarely indicate pancreatitis a known risk with GLP-1 receptor agonist therapies or gallbladder problems [18] [21] Rapid or irregular heartbeat (palpitations) Significant injection site reactions, including signs of infection (redness, warmth, swelling, or discharge) Symptoms of low blood sugar (hypoglycaemia) if you are also taking insulin or a sulfonylurea, such as shakiness, sweating, or confusion If you are unsure whether your symptoms require urgent attention, contact NHS 111 (by phone or online at 111.nhs.uk) for advice
Are there side effects to GLP-1 medications
The 60-day guarantee provides a risk-reduced evaluation window - though the timing relative to the 2-package supply is tight
The paper is part of a wider research funded by the Ministry of Research that investigates not only the tourist sector, but also the industry, logistics, and higher education in the three case studies mentioned above.Speaker: Dr Flavia Giallorenzo (Universit degli Studi di Firenze) 80 From Global Indicators to Local Solutions: How to Foster Responsible Tourism for Rural Heritage Conservation The 1970s saw a significant increase in visitors to historical sites, leading to problems in managing these sites and the development of concepts in tourism and urban literature, such as tourism carrying capacity (Kuss and Morgan, 1980), tolerance model (Doxey, 1975), and tourist perspective (Urry, 1990)
Many patients report fewer cravings and feel more in control of food decisions after starting treatment